Correlation Between Alector and Aclaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alector and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alector and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alector and Aclaris Therapeutics, you can compare the effects of market volatilities on Alector and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alector with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alector and Aclaris Therapeutics.
Diversification Opportunities for Alector and Aclaris Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alector and Aclaris is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Alector and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Alector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alector are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Alector i.e., Alector and Aclaris Therapeutics go up and down completely randomly.
Pair Corralation between Alector and Aclaris Therapeutics
Given the investment horizon of 90 days Alector is expected to under-perform the Aclaris Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Alector is 2.73 times less risky than Aclaris Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Aclaris Therapeutics is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 161.00 in Aclaris Therapeutics on August 27, 2024 and sell it today you would earn a total of 238.00 from holding Aclaris Therapeutics or generate 147.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alector vs. Aclaris Therapeutics
Performance |
| Timeline |
| Alector |
| Aclaris Therapeutics |
Alector and Aclaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alector and Aclaris Therapeutics
The main advantage of trading using opposite Alector and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alector position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.| Alector vs. Eliem Therapeutics | Alector vs. HCW Biologics | Alector vs. Scpharmaceuticals | Alector vs. Milestone Pharmaceuticals |
| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |